Rapid detection of neuron specific enolase by chemiluminescence immunoassay using bio-functionlized magnetic nanocomposites

To detect a biomarker for small cell lung carcinoma (SCLC), neuron specific enolase (NSE), a chemiluminescent immunoassay combined with immunomagnetic separation was proposed, in which bio-functionalized magnetic nanocomposites (BFMNs) were used as mobile substrate for capturing and isolating the NSE proteins. The BFMNs coated with anti-NSE antibody would connect with NSE and horseradish peroxidase labeled anti-NSE antibody in a sandwich-type detection manner. After fast magnetic collection, the sandwich immunocomplex is separated from excess antiboby or non-specific proteins. The immunocomplex further reacts with chemiluminescent substrate to produce chemiluminescence. A home-made three-channel luminometer was used to detect the chemiluminescence so as to improve the detection speed. There is a good linear response between the chemiluminescence intensity and the NSE concentration in the range from 2 to 200 ng/mL. The proposed immunoassay also shows good reproducibility and excellent selectivity for NSE against other proteins. The whole detection process including incubation, washing and detection could be performed within 40 min. The proposed method offers a simple, noninvasive and reliable tool for detecting SCLC and has potential application for clinical testing.

[1]  P. Lamy,et al.  Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. , 2003, Lung cancer.

[2]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[3]  Zhijuan Cao,et al.  Cross-talk-free simultaneous fluoroimmunoassay of two biomarkers based on dual-color quantum dots. , 2011, Analytica chimica acta.

[4]  Yukiko Nakamura,et al.  Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer. , 2012, Lung cancer.

[5]  K. Kiura,et al.  Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). , 2001, Lung cancer.

[6]  M. L. Rosado de Christenson Screen-detected Lung Cancer: A Retrospective Analysis of CT Appearance , 2012 .

[7]  R. Molina,et al.  Diagnostic relevance of circulating biomarkers in patients with lung cancer. , 2010, Cancer biomarkers : section A of Disease markers.

[8]  Wei Guan,et al.  An electrochemical immunosensor for simultaneous multiplexed detection of neuron-specific enolase and pro-gastrin-releasing peptide using liposomes as enhancer , 2011 .

[9]  D. Ferrigno,et al.  Clinical applications of serum markers for lung cancer. , 1995, Respiratory medicine.

[10]  G. Fonnum,et al.  Characterisation of Dynabeads® by magnetization measurements and Mössbauer spectroscopy , 2005 .

[11]  I. Weeks,et al.  Chemiluminescence immunoassay: an overview. , 1986, Clinical science.

[12]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[13]  Xinxia Cai,et al.  A rapid and highly sensitive portable chemiluminescent immunosensor of carcinoembryonic antigen based on immunomagnetic separation in human serum. , 2013, Analytica chimica acta.